- Home
- ATOS vs BOOM Comparison
ATOS vs BOOM Comparison
Compare ATOS & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- BOOM
- Stock Information
- Founded
- ATOS 2009
- BOOM 1965
- Country
- ATOS United States
- BOOM United States
- Employees
- ATOS N/A
- BOOM N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- BOOM Industrial Specialties
- Sector
- ATOS Health Care
- BOOM Industrials
- Exchange
- ATOS Nasdaq
- BOOM Nasdaq
- Market Cap
- ATOS 112.5M
- BOOM 130.3M
- IPO Year
- ATOS 2012
- BOOM N/A
- Fundamental
- Price
- ATOS $0.86
- BOOM $8.02
- Analyst Decision
- ATOS Strong Buy
- BOOM Buy
- Analyst Count
- ATOS 4
- BOOM 2
- Target Price
- ATOS $6.17
- BOOM $16.25
- AVG Volume (30 Days)
- ATOS 668.8K
- BOOM 158.5K
- Earning Date
- ATOS 05-13-2025
- BOOM 07-31-2025
- Dividend Yield
- ATOS N/A
- BOOM N/A
- EPS Growth
- ATOS N/A
- BOOM N/A
- EPS
- ATOS N/A
- BOOM N/A
- Revenue
- ATOS N/A
- BOOM $635,272,000.00
- Revenue This Year
- ATOS N/A
- BOOM N/A
- Revenue Next Year
- ATOS N/A
- BOOM $4.32
- P/E Ratio
- ATOS N/A
- BOOM N/A
- Revenue Growth
- ATOS N/A
- BOOM N/A
- 52 Week Low
- ATOS $0.55
- BOOM $6.02
- 52 Week High
- ATOS $1.66
- BOOM $15.14
- Technical
- Relative Strength Index (RSI)
- ATOS 51.39
- BOOM 69.54
- Support Level
- ATOS $0.84
- BOOM $6.92
- Resistance Level
- ATOS $0.93
- BOOM $8.04
- Average True Range (ATR)
- ATOS 0.06
- BOOM 0.31
- MACD
- ATOS -0.00
- BOOM 0.16
- Stochastic Oscillator
- ATOS 66.40
- BOOM 96.26
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About BOOM DMC Global Inc.
DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.